233 related articles for article (PubMed ID: 3006953)
1. Systemic lupus erythematosus sera antilymphocyte reactivity: detection of antibodies to Tac-antigen positive T cell lines.
Sano H; Kumagai S; Namiuchi S; Uchiyama T; Yodoi J; Maeda M; Takatsuki K; Suginoshita T; Imura H
Clin Exp Immunol; 1986 Jan; 63(1):8-16. PubMed ID: 3006953
[TBL] [Abstract][Full Text] [Related]
2. TCGF (IL 2)-receptor inducing factor(s). I. Regulation of IL 2 receptor on a natural killer-like cell line (YT cells).
Yodoi J; Teshigawara K; Nikaido T; Fukui K; Noma T; Honjo T; Takigawa M; Sasaki M; Minato N; Tsudo M
J Immunol; 1985 Mar; 134(3):1623-30. PubMed ID: 2578514
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-2 receptor (Tac antigen) expressed on adult T cell leukemia cells.
Uchiyama T; Hori T; Tsudo M; Wano Y; Umadome H; Tamori S; Yodoi J; Maeda M; Sawami H; Uchino H
J Clin Invest; 1985 Aug; 76(2):446-53. PubMed ID: 2993359
[TBL] [Abstract][Full Text] [Related]
4. Abnormal expression of interleukin-2 receptor (Tac antigen) in adult T-cell leukemia.
Uchiyama T; Wano Y; Tsudo M; Umadome H; Hori T; Tamori S; Uchino H; Yodoi J; Maeda M; Kobayashi N
Princess Takamatsu Symp; 1984; 15():253-8. PubMed ID: 6100643
[TBL] [Abstract][Full Text] [Related]
5. IgG anti-lymphocyte antibodies in systemic lupus erythematosus react with surface molecules shared by peripheral T cells and a primitive T cell line.
Minota S; Winfield JB
J Immunol; 1987 Mar; 138(6):1750-6. PubMed ID: 3102598
[TBL] [Abstract][Full Text] [Related]
6. Modulation of IgM anti-lymphocyte antibody-reactive T cell surface antigens in systemic lupus erythematosus.
Winfield JB; Shaw M; Minota S
J Immunol; 1986 May; 136(9):3246-53. PubMed ID: 3007614
[TBL] [Abstract][Full Text] [Related]
7. Production of a monoclonal antibody to a membrane antigen of human T-cell leukaemia virus (HTLV1/ATLV)-infected cell lines from a systemic lupus erythematosus (SLE) patient: serological analyses for HTLV1 infections in SLE patients.
Kurata A; Katamine S; Fukuda T; Mine M; Ikari N; Kanazawa H; Matsunaga M; Eguchi K; Nagataki S
Clin Exp Immunol; 1985 Oct; 62(1):65-74. PubMed ID: 2998659
[TBL] [Abstract][Full Text] [Related]
8. Antibody to activated lymphocytes in patients with systemic lupus erythematosus.
Kagami M; Koike T; Takabayashi K; Tomioka H; Yoshida S
J Rheumatol; 1987 Oct; 14(5):907-12. PubMed ID: 3123675
[TBL] [Abstract][Full Text] [Related]
9. Two mouse monoclonal antibodies detecting two different epitopes of an activated lymphocyte antigen on adult T-cell leukemia cells.
Ueda R; Nishida K; Koide Y; Tsuge I; Seto M; Yoshida M; Miyoshi I; Ota K; Takahashi T
Cancer Res; 1985 Mar; 45(3):1314-9. PubMed ID: 2578877
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-2 receptor expression in retrovirus associated adult T-cell leukemia.
Waldmann TA; Leonard WJ; Depper JM; Krönke M; Goldman CK; Oh T; Greene WC
Princess Takamatsu Symp; 1984; 15():259-68. PubMed ID: 6100644
[TBL] [Abstract][Full Text] [Related]
11. The role of the multichain IL-2 receptor complex in the control of normal and malignant T-cell proliferation.
Waldmann TA; Tsudo M
Prog Clin Biol Res; 1988; 262():283-93. PubMed ID: 2897696
[TBL] [Abstract][Full Text] [Related]
12. Low responsiveness to the anti Leu 4 antibody by T cells from patients with active systemic lupus erythematosus.
Kaneoka H; Morito F; Yamaguchi M
J Clin Lab Immunol; 1989 Jan; 28(1):15-26. PubMed ID: 2470907
[TBL] [Abstract][Full Text] [Related]
13. Characterization of human interleukin 2 receptor (Tac antigen) in normal and leukemic T cells: co-expression of normal and aberrant receptors on Hut-102 cells.
Wano Y; Uchiyama T; Fukui K; Maeda M; Uchino H; Yodoi J
J Immunol; 1984 Jun; 132(6):3005-10. PubMed ID: 6327813
[TBL] [Abstract][Full Text] [Related]
14. Cell surface phenotype and in vitro function of adult T-cell leukemia cells.
Uchiyama T; Hattori T; Wano Y; Tsudo M; Takatsuki K; Uchino H
Diagn Immunol; 1983; 1(3):150-4. PubMed ID: 6094084
[TBL] [Abstract][Full Text] [Related]
15. Cell surface differentiation antigens of the malignant T cell in Sezary syndrome and mycosis fungoides.
Haynes BF; Bunn P; Mann D; Thomas C; Eisenbarth GS; Minna J; Fauci AS
J Clin Invest; 1981 Feb; 67(2):523-30. PubMed ID: 6970206
[TBL] [Abstract][Full Text] [Related]
16. Suppressor-cell antibody in systemic lupus erythematosus. Possible mechanism for suppressor-cell dysfunction.
Sagawa A; Abdou NI
J Clin Invest; 1979 Mar; 63(3):536-9. PubMed ID: 311787
[TBL] [Abstract][Full Text] [Related]
17. Production of lymphokines by circulating human T lymphocytes that express or lack receptors for interleukin 2.
Palacios R
J Immunol; 1984 Apr; 132(4):1833-6. PubMed ID: 6321592
[TBL] [Abstract][Full Text] [Related]
18. Identification of three major target molecules of IgM antilymphocyte autoantibodies in systemic lupus erythematosus.
Minota S; Winfield JB
J Immunol; 1987 Dec; 139(11):3644-51. PubMed ID: 3500225
[TBL] [Abstract][Full Text] [Related]
19. Studies on antilymphocyte antibodies in patients with rheumatoid arthritis and systemic lupus erythematosus.
Winchester RJ; Winfield JB; Fu SM; Wernet P; Kunkel HG
Rheumatology; 1975; 6():209-14. PubMed ID: 1081726
[TBL] [Abstract][Full Text] [Related]
20. [Lymphocyte imbalance in autoimmunity].
Manni JA; Guilleron C; Araujo HA
Medicina (B Aires); 1989; 49(2):105-8. PubMed ID: 2640477
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
